← All stocks

LENZ Therapeutics, Inc.

LENZ Net selling

CIK 0001815776 #4144 in the set updated 18 Sep 2026

Bought (12 mo)

$654.87K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$16.33M

$0.00 on a plan · $261.02K straight out of an exercise

Sold at will

$16.07M

12 of 14 sales

Net

−$15.67M

−$15.41M against sales at will

By person

6 insiders · 20 transactions

0.9×

Evert Schimmelpennink holds only 0.9 times base salary in stock. $662.37K of shares against $690.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Evert Schimmelpennink last reported holding, valued at $8.57, the price Common Stock was last bought or sold at on the open market here, on 27 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Versant Venture Capital VI, L.P. entity

10% owner

—

$16.07M (12)

−$16.07M

1,814,726

5.78%

$15.55M

−51.0%

Olsson Shawn

Chief Commercial Officer

—

$261.02K (2) scheduled

−$261.02K

4,733

0.0151%

$40.56K

—

Schimmelpennink Evert B.

President, CEO and Secretary

$251.41K (1)

—

+$251.41K

77,289

0.2460%

$662.37K

+71.8%

MCCOLLUM JAMES W

Director

$239.28K (1)

—

+$239.28K

10,500

0.0334%

$89.99K

—

Chevallard Daniel R.

Chief Financial Officer

$114.29K (3)

—

+$114.29K

12,886

0.0410%

$110.43K

+304.2%

George Jeffrey P.

Director

$49.89K (1)

—

+$49.89K

5,592

0.0178%

$47.92K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 19

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 2

Sales at will 12

Transactions with no price 0

Shares from compensation/vesting 10,000

History held since 28 Jun 2021